Earnings Review
Apollo Hosp Jan-Mar consol PAT up 53.5% on year, above view
This story was originally published at 19:34 IST on 30 May 2025
Register to read our real-time news.Informist, Friday, May 30, 2025
Please click here to read all liners published on this story
--Apollo Hosp arm HealthCo net added 266 stores Jan-Mar, total stores 6,626
--Apollo Hosp operating beds at 8,025 as on Mar 31
--Apollo Hosp Jan-Mar hospitals ops occupancy rate 67% vs 65% year ago
--Apollo Hosp arm Health & Lifestyle Jan-Mar EBITDA INR 472 mln, up 32% on yr
--Apollo Hosp arm HealthCo Jan-Mar EBITDA INR 363 mln vs INR 117 mln yr ago
--Apollo Hosp arm HealthCo Jan-Mar sales INR 23.8 bln vs INR 20.3 bln yr ago
--Apollo Hosp Jan-Mar healthcare svcs ops EBITDA INR 6.86 bln, up 16% on yr
--Apollo Hosp Jan-Mar health & lifestyle sales INR 3.94 bln vs INR 3.55 bln
--Apollo Hosp Jan-Mar consol EBITDA INR 7.70 bln, up 20% on year
--Apollo Hosp Jan-Mar healthcare svcs sales INR 28.43 bln vs INR 25.80 bln
--Apollo Hosp FY25 consol revenue INR 217.94 bln vs INR 190.59 bln year ago
--Apollo Hosp FY25 consol PAT INR 14.46 bln vs INR 8.99 bln year ago
--Apollo Hosp to pay INR 10 per share final dividend
--Apollo Hosp Jan-Mar consol revenue INR 55.92 bln vs INR 49.44 bln year ago
--Apollo Hosp Jan-Mar consol PAT INR 3.90 bln vs INR 2.54 bln year ago
--Analysts saw Apollo Hosp Jan-Mar consol net profit INR 3.64 bln
--Apollo Hosp Jan-Mar consol net profit INR 3.90 bln
By Narayana Krishna
HYDERABAD – Apollo Hospitals Enterprise Ltd. Friday reported a consolidated net profit of INR 3.9 billion for March quarter, up 53.5% on year and 4.7% on quarter, which was above analysts' estimates. The Chennai-based healthcare services and pharmacy retailing company reported a 13% on year and a 1.2% sequential growth in its consolidated revenue from operations to INR 55.9 billion for the quarter, in line with the estimates. Analysts had estimated Apollo Hospitals' March quarter net profit at INR 3.64 billion on a revenue of INR 55.8 billion.
The company reported over 10% on-year growth in its healthcare services or hospital business to INR 28.43 billion. Healthcare services, comprising of network of hospitals contribute over 51% of the company's total revenue. As of Mar. 31, Apollo Hospitals had a total of 8,025 operating beds across the network and the occupancy for the quarter improved to 67% from 65% a year ago, the company said in a press release.
Apollo Hospitals' March quarter consolidated earnings before interest, tax, depreciation, and amortisation were up 20% on year at INR 7.70 billion, marginally above the expectations of INR 7.65 billion. Healthcare services segment's EBITDA for the quarter was up 16% on year to INR 6.86 billion, helping the company report healthy earnings growth for the quarter.
Apollo HealthCo Ltd, a subsidiary of Apollo Hospitals and holding company of pharmacy retailing, distribution and digital platform Apollo 24/7, reported a 17% on-year growth in in revenues to INR 23.8 billion. The subsidiary's EBITDA for the quarter improved to INR 363 million from 117 million a year ago.
Apollo HealthCo added 266 new Apollo Pharmacy stores in March quarter, taking the total store count to 6,626. The gross merchandise value booked on Apollo 24/7 platform was up 11% on year at INR 7.95 billion for the quarter. The average order intake on the digital platform improved to INR 83,000 per day in the March quarter from INR 58,000 a year ago.
Another arm, Apollo Health & Lifestyle Ltd., which operates diagnostics and clinics under Apollo brand reported a revenue of INR 3.94 billion, up 11% on year, while its EBITDA rose 32% on year to INR 472 million.
For 2024-25 (Apr-Mar), Apollo Hospitals reported a consolidated net profit of INR 14.46 billion, up 61%, and revenue rose 14% on year to INR 217.94 billion. The company's board today approved INR 10 per share as final dividend. Friday, Apollo Hospitals' shares ended at INR 6,880.50 on the National Stock Exchange, down 0.6% from its previous close. End
Edited by Akul Nishant Akhoury
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2025. All rights reserved.
To read more please subscribe
Share this Story:
